Cargando…

Overlap between Central and Peripheral Transcriptomes in Parkinson’s Disease but Not Alzheimer’s Disease

Most neurodegenerative disorders take decades to develop, and their early detection is challenged by confounding non-pathological ageing processes. Therefore, the discovery of genes and molecular pathways in both peripheral and brain tissues that are highly predictive of disease evolution is necessa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hooshmand, Kosar, Halliday, Glenda M., Pineda, Sandy S., Sutherland, Greg T., Guennewig, Boris
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9104085/ https://www.ncbi.nlm.nih.gov/pubmed/35563596 http://dx.doi.org/10.3390/ijms23095200

Ejemplares similares

Vascular Dysfunction Is Central to Alzheimer’s Disease Pathogenesis in APOE e4 Carriers
por: McCorkindale, Andrew N., et al.
Publicado: (2022)

Defining early changes in Alzheimer’s disease from RNA sequencing of brain regions differentially affected by pathology
por: Guennewig, Boris, et al.
Publicado: (2021)

Machine learning analysis of the UK Biobank reveals IGF-1 and inflammatory biomarkers predict Parkinson’s disease risk
por: Allwright, Michael, et al.
Publicado: (2023)

Author Correction: Defining early changes in Alzheimer’s disease from RNA sequencing of brain regions differentially affected by pathology
por: Guennewig, Boris, et al.
Publicado: (2021)

Author Correction: Defining early changes in Alzheimer’s disease from RNA sequencing of brain regions differentially affected by pathology
por: Guennewig, Boris, et al.
Publicado: (2023)

The Key Factors Predicting Dementia in Individuals With Alzheimer’s Disease-Type Pathology
por: McCorkindale, Andrew N., et al.
Publicado: (2022)

Ranking the risk factors for Alzheimer’s disease; findings from the UK Biobank study
por: Allwright, Michael, et al.
Publicado: (2023)

Genetic overlap between Alzheimer’s disease and Parkinson’s disease at the MAPT locus
por: Desikan, Rahul S., et al.
Publicado: (2015)

Peripheral vs. Central Sex Steroid Hormones in Experimental Parkinson’s Disease
por: McArthur, Simon, et al.
Publicado: (2011)

Dissecting the limited genetic overlap of Parkinson's and Alzheimer's disease
por: Stolp Andersen, Maren, et al.
Publicado: (2022)

Overlap between Parkinson disease and Alzheimer disease in ABCA7 functional variants
por: Nuytemans, Karen, et al.
Publicado: (2016)

The overlap between Alzheimer's disease and epilepsy uncovered by transcriptome sequencing
por: Jiang, Xiaowen, et al.
Publicado: (2020)

Aspects of Innate Immunity and Parkinson’s Disease
por: Huang, Yue, et al.
Publicado: (2012)

New perspectives on cytoskeletal dysregulation and mitochondrial mislocalization in amyotrophic lateral sclerosis
por: Theunissen, Frances, et al.
Publicado: (2021)

Polygenic risk of paclitaxel-induced peripheral neuropathy: a genome-wide association study
por: Hooshmand, Kosar, et al.
Publicado: (2022)

Parkinson’s disease-implicated kinases in the brain; insights into disease pathogenesis
por: Dzamko, Nicolas, et al.
Publicado: (2014)

Transcriptomic and Genetic Associations between Alzheimer’s Disease, Parkinson’s Disease, and Cancer
por: Forés-Martos, Jaume, et al.
Publicado: (2021)

Genetic overlap between Parkinson’s disease and inflammatory bowel disease
por: Kang, Xiaoying, et al.
Publicado: (2023)

Single-cell peripheral immunoprofiling of Alzheimer’s and Parkinson’s diseases
por: Phongpreecha, Thanaphong, et al.
Publicado: (2020)

The acute phase protein lactoferrin is a key feature of Alzheimer’s disease and predictor of Aβ burden through induction of APP amyloidogenic processing
por: Tsatsanis, Andrew, et al.
Publicado: (2021)

Central and peripheral circadian clocks and their role in Alzheimer's disease
por: Chauhan, Ruchi, et al.
Publicado: (2017)

The overlap between vascular disease and Alzheimer’s disease - lessons from pathology
por: Attems, Johannes, et al.
Publicado: (2014)

Apolipoprotein D Upregulation in Alzheimer’s Disease but Not Frontotemporal Dementia
por: Bhatia, Surabhi, et al.
Publicado: (2018)

Central and Peripheral Inflammation: Connecting the Immune Responses of Parkinson’s Disease
por: Williams, Gregory P., et al.
Publicado: (2022)

Toward refining Alzheimer's disease into overlapping subgroups
por: Hascup, Erin R., et al.
Publicado: (2020)

Immune Responses in Parkinson's Disease: Interplay between Central and Peripheral Immune Systems
por: Su, Xiaomin, et al.
Publicado: (2014)

Symptomatic, Genetic, and Mechanistic Overlaps between Autism and Alzheimer’s Disease
por: Nadeem, Muhammad Shahid, et al.
Publicado: (2021)

MRI and Clinical Biomarkers Overlap between Glaucoma and Alzheimer’s Disease
por: Martucci, Alessio, et al.
Publicado: (2023)

Peripheral transcriptomic biomarkers for early detection of sporadic Alzheimer disease?
por: Hadar, Adva, et al.
Publicado: (2018)

Antihypertensive medications ameliorate Alzheimer's disease pathology by slowing its propagation
por: Affleck, Andrew J., et al.
Publicado: (2020)

Neurodegeneration in Alzheimer’s disease and glaucoma: overlaps and missing links
por: Sen, Sagnik, et al.
Publicado: (2020)

Genetic Overlap Between Alzheimer’s Disease and Depression Mapped Onto the Brain
por: Monereo-Sánchez, Jennifer, et al.
Publicado: (2021)

PARK Genes Link Mitochondrial Dysfunction and Alpha-Synuclein Pathology in Sporadic Parkinson’s Disease
por: Li, Wen, et al.
Publicado: (2021)

The relationships between mild cognitive impairment and phenotype in Parkinson’s disease
por: Szeto, Jennifer YY, et al.
Publicado: (2015)

Peripheral and central effects of γ-secretase inhibition by semagacestat in Alzheimer’s disease
por: Doody, Rachelle S, et al.
Publicado: (2015)

Central and Peripheral Inflammation in Mild Cognitive Impairment in the Context of Alzheimer’s Disease
por: Schmidt-Morgenroth, Inès, et al.
Publicado: (2023)

Lipid pathway dysfunction is prevalent in patients with Parkinson’s disease
por: Galper, Jasmin, et al.
Publicado: (2022)

Transcriptome deregulation of peripheral monocytes and whole blood in GBA-related Parkinson’s disease
por: Riboldi, Giulietta Maria, et al.
Publicado: (2022)

PART is part of Alzheimer disease
por: Duyckaerts, Charles, et al.
Publicado: (2015)

Central and peripheral α‐synuclein in Parkinson disease detected by seed amplification assay
por: Chahine, Lana M., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_dl5ea3rqflabulj0kqfhstapu1